Bosh sahifaSHTDY • OTCMKTS
add
Sinopharm Group ADR
13,26 $
Seans yopilganidan keyin:(0,27%)+0,036
13,30 $
Yopilgan:2-apr, 16:00:01 (GMT-4) · USD · OTCMKTS · Ogohlantirish
Yopilish kursi
13,00 $
Kunlik diapazon
13,26 $ - 13,36 $
Yillik diapazon
10,77 $ - 14,87 $
Bozor kapitalizatsiyasi
65,28 mlrd HKD
Oʻrtacha hajm
78,07 ming
Narx/foyda
-
Dividend daromadliligi
-
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (CNY) | dek, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 143,69 mlrd | 1,13% |
Joriy xarajat | 5,00 mlrd | -10,42% |
Sof foyda | 1,85 mlrd | 4,36% |
Sof foyda marjasi | 1,29 | 3,20% |
Har bir ulushga tushum | — | — |
EBITDA | 5,97 mlrd | -2,51% |
Amaldagi soliq stavkasi | 30,30% | — |
Balans
Jami aktivlari
Jami passivlari
| (CNY) | dek, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 48,80 mlrd | -10,16% |
Jami aktivlari | 390,36 mlrd | -0,63% |
Jami passivlari | 256,20 mlrd | -3,74% |
Umumiy kapital | 134,16 mlrd | — |
Tarqatilgan aksiyalar | 3,12 mlrd | — |
Narxi/balansdagi bahosi | 0,48 | — |
Aktivlardan daromad | 3,34% | — |
Kapitaldan daromad | 6,42% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (CNY) | dek, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 1,85 mlrd | 4,36% |
Operatsiyalardan naqd pul | 53,22 mlrd | -10,21% |
Sarmoyadan naqd pul | -1,21 mlrd | 67,09% |
Moliyadan naqd pul | -30,23 mlrd | 18,95% |
Naqd pulning sof oʻzgarishi | 21,77 mlrd | 19,12% |
Boʻsh pul | 24,05 mlrd | — |
Haqida
Sinopharm Group Co., Ltd. is a Chinese pharmaceutical company. The parent company of Sinopharm Group was Sinopharm Industrial Investment, a 51–49 joint venture of state-owned enterprise China National Pharmaceutical Group and civilian-run enterprise Fosun Pharmaceutical.
Its H shares were listed on the Hong Kong Stock Exchange in 2009, with its IPO price of HK$16 per share. Sinopharm Group's subsidiary Sinopharm CNMC and Sinopharm Accord served as the A share counterpart of the company. However, the A share of Sinopharm Group itself was unlisted.
Sinopharm Group was ranked 829th in 2016 Forbes Global 2000 list. Wikipedia
Tashkil etilgan
2003
Sayt
Xodimlar soni
94 910